Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,794 | -54,369 | -40,237 | -25,550 | -16,743 |
| Depreciation Amortization | 345 | 793 | 572 | 314 | 157 |
| Other Working Capital | 7,272 | -13,898 | -14,022 | -9,308 | 9,668 |
| Other Operating Activity | 4,567 | 17,252 | 13,867 | 7,451 | 1,136 |
| Operating Cash Flow | $-13,610 | $-50,222 | $-39,820 | $-27,093 | $-5,782 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-16 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 38,708 | 9,996 | 9,996 | 9,996 |
| Common Stock Issued | 816 | 58,858 | 58,861 | 58,813 | 58,689 |
| Other Financing Activity | -3,939 | -4,697 | 0 | 0 | 0 |
| Financing Cash Flow | $-3,123 | $92,869 | $68,857 | $68,809 | $68,685 |
| Exchange Rate Effect | -141 | 1,298 | 502 | 1,184 | 685 |
| Beginning Cash Position | 271,772 | 227,827 | 227,827 | 227,827 | 227,827 |
| End Cash Position | 254,882 | 271,772 | 257,366 | 270,727 | 291,415 |
| Net Cash Flow | $-16,890 | $43,945 | $29,539 | $42,900 | $63,588 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,610 | -50,222 | -39,820 | -27,093 | -5,782 |
| Capital Expenditure | -16 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -13,626 | -50,222 | -39,820 | -27,093 | -5,782 |